Skip to main content
NCBI home page
Medicine logoLink to Medicine
. 2015 Nov 20;94(46):e1884. doi: 10.1097/MD.0000000000001884

Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer

An Updated Meta-Analysis Based on GWAS Results

Kunhou Yao 1, Long Hua 1, Lunshou Wei 1, Jiming Meng 1, Junhong Hu 1
Editor: Maria Kapritsou1
PMCID: PMC4652810  PMID: 26579801

Abstract

Genome-wide association studies (GWASs) and a number of case–control studies have suggested that several single nucleotide polymorphisms (SNPs), rs7837328, rs7014346, rs6983267, rs10505477 on CASC8 gene and rs4939827, rs4464148, rs12953717 on SMAD7 gene are significantly correlated with the susceptibility to colorectal cancer (CRC). For the sake of clarifying the association, a meta-analysis was conducted and population heterogeneity was considered in the study.

A total of 34 articles including 90 studies (168,471 cases and 163,223 controls) that evaluated the relationship between the CASC8, SMAD7 genes and the risk of CRC under the allelic model were reviewed. Also subgroup analysis was performed by ethnicity (Caucasian, Asian, and African) and all of the analyses were implemented in R 3.2.1 software.

Pooled data from the meta-analysis revealed that the A allele of rs7837328, the A allele of rs7014346, the G allele of rs6983267, the A allele of rs10505477, the T allele of rs4939827, the T of rs4464148, and the T of rs12953717 were significantly associated with an increased risk of CRC under the allelic model. Additionally, subgroup analyses of 6 SNPs by ethnicity (rs4464148 excepted) witnessed that the A allele of rs7837328, the G allele of rs6983267, and the T of rs12953717 were notably associated with an increased risk of CRC among Caucasian and Asian. Furthermore, the A allele of rs7014346, the A allele of rs10505477, and the T allele of rs4939827 were significantly related with an elevated risk of CRC only among Caucasian.

Our study suggested that for CASC8 gene, SNP of rs7837328 and rs6983267 are risk factors for CRC among both Caucasian and Asian whereas rs7014346 and rs10505477 are risky gene polymorphisms only among Caucasian. For SMAD7 gene, rs4939827 and rs4464148 are risk factors for CRC among Caucasian whereas rs12953717 could elevate the susceptibility to CRC in both Caucasian and Asian.

INTRODUCTION

Colorectal cancer (CRC) is one of the most prevailing cancer occurred in the digestive system,1 and it ranked as the third primary cancer-causing death in the world.2 CRC is a multistep, multifactorial disease that results from various factors. Previous epidemiological studies have shown that lifestyle and dietary factors (smoking, unhealthy dietary intake, occupational exposures to chemicals, etc.) are common risk factors for the development of CRC.3,4 Although the pathogenesis of CRC is still unclear, molecular epidemiological studies have suggested that single nucleotide polymorphisms (SNPs) in genes play a vital role in CRC development and progression.5,6 Genome-wide association studies (GWASs) have revealed that genetic factors accounted for 33% of CRC cases in the world.7–9

Cancer susceptibility candidate 8 (CASC8) gene, a long noncoding RNA (lncRNA), is located in the region of 8q24.21, which is a nonprotein coding region.10 LncRNA is a new class of transcripts, which transcribed pervasively in the genome and regulates the expression of multiple genes.11 Studies have shown that SNPs in lncRNAs may affect the biological process of messenger RNA conformation, and result in the modification of its interacting partners.12,13 In addition to protein coding genes and microRNAs, the dysregulated expression of lncRNAs is likely to be pervasive in human cancers and can regulate tumorigenesis and predict tumor prognosis.14 Various cancer including prostate cancer,15 breast cancer, CRC, and gastric cancer have been reported to be correlated with the CACS8 gene.10 Although some well-featured studies suggested the association between CASC8 gene SNP and the risk of CRC, few of them provided evidence that multiple SNPs in genes were correlated with the risk of CRC.

On the other hand, SMAD7 gene, located in the region of 18q21, is one of the members of transforming growth factor-β (TGF-β) family signaling pathway. It has been proved to promote the antiinflammatory effects of TGF-β signaling via binding to TAB2 and TAB3 and inhibiting TAK1.16,17 Apart from that, TGF-β plays an important role in promoting metastasis in many solid tumors.18 Studies have indicated that SMAD7 gene is related with breast cancer,19 gastric cancer,20 pancreatic cancer,21 CRC,22 and so on. Great efforts have been made to investigate the association between SMAD7 gene polymorphisms and the risk of CRC. Nevertheless, the functional significance of these SNPs is still unclear.

Several studies have evaluated the association between parts of gene polymorphisms and the susceptibility to CRC risk, but the associations suggested by different studies were inconsistent. Besides that, a single case–control study may fail to discover the effects of gene polymorphisms on the susceptibility to CRC due to various genotypes and the small sample size. However, meta-analysis has the advantage of increased statistical power and reduced random error which could generate more accurate statistical results than that in individual studies. As a result of this, a meta-analysis with eligible studies was carried out to provide an integrated understanding of the impact of CACS8 and SMAD7 gene polymorphisms on the susceptibility to CRC. Subgroup analyses were performed in order to explore potential sources of heterogeneity among individual studies.

METHODS

Ethical approval was not necessary for the current meta-analysis.

Search Strategy and Selection

A meta-analysis was carried out based on the guidelines of PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement.23 Using the following MeSH searching terms: “colorectal cancer,” “polymorphism,” “rs7837328,” “rs7014346,” “rs6983267,” “rs10505477,” “rs4939827,” “rs4464148,” “rs12953717,” “case–control,” and “meta-analysis,” articles were searched electronically in PubMed, MEDLINE, and Embase without language restrictions. Additionally, the reference lists in each relevant article were searched manually for other related publications.

Data Extraction

The following criteria were used as the inclusion criteria for relevant studies: patients in the study were diagnosed with CRC at any tumorigenesis stage; subjects in the control group were healthy and free from cancer or neoplasm; availability of genotype or allele of the case and control groups or minor allele frequency (MAF) of the case and control group or related odds ratio (OR) and confidence interval (95% CI) for the allelic model of CRC; and genotype distributions complied with Hardy–Weinberg equilibrium. The following criteria were set as the primary exclusion criteria: CRC patients with other cancer; no available data of genotype or allele frequencies or MAF or related OR; abstracts and reviews; and duplicated publications.

These studies were screened by 2 independent investigators and relevant information was individually extracted from all qualified publications. Disagreements between the 2 investigators were recorded and settled by a discussion with a third investigator. Finally, the following information was collected from each qualified study: author of surname, year of publication, ethnicity of subjects, sample sizes of the case and control group, frequency distributions of genotype and allele, OR and 95% CI of the allelic model.

Statistical Analysis

A Chi-squared (χ2) test was conducted to investigate the heterogeneity among individual studies. The fixed-effects model was used if there was no significant heterogeneity among individual studies (I2 < 50%, P > 0.05), otherwise, the random-effects model was applied in the meta-analysis. Pooled ORs were calculated for the allelic model to estimate the association between CASC8, SMAD7 gene polymorphisms and CRC. Moreover, Z test was used to assess the statistical significance of the pooled OR and Begg funnel plot was carried out to determine whether or not there was significant publication bias. A value of P < 0.05 suggests that statistically significant bias was presented in the meta-analysis. All of the statistical analyses were implemented using R 3.2.1 software and a 2-tailed P-value of less than 0.05 was considered as the significant level.

RESULTS

Study Characteristics

As shown in Figure 1, 121 reports were selected initially using the MeSH searching terms and 91 articles were excluded after initial screening of titles and abstracts. Eventually, 34 articles met the inclusion criteria and 4 extra reference articles were added using manual searching. Newcastle-Ottawa Scale (NOS) was used for quality assessment, and all of the 34 studies achieved moderately high quality with scores above 6 (Supplement Figure S1). The main characteristics of included studies were shown in Supplement Table S1. There were 34 articles including 90 case–control studies in total and some of the articles contained multiple studies as they investigated multiple SNPs and different ethnicity. Furthermore, a total of 90 studies were further classified by ethnicity (Asian, African, and Caucasian) for subgroup analysis. Among included studies, 4 studies were conducted on rs7837328 (6167 cases and 5978 controls), 13 studies on rs7014346 (22,685 cases and 20,794 controls), 27 studies on rs6983267 (47,461 cases and 46,958 controls), 11 studies on rs10505477 (15,584 cases and 17,613 controls), 21 studies on rs4939827 (47,029 cases and 43,779 controls), 4 studies on rs4464148 (12,508 cases and 11,337 controls), and 10 studies on rs12953717 (17,037 cases and 16,764 controls).

FIGURE 1.

FIGURE 1

Open in a new tab

Studies selection flowchart the meta-analysis.

Meta-Analysis Results

The association between the above 7 SNPs on gene CASC8, SMAD7 and with the susceptibility to CRC in the allelic model are revealed in Table 1. A detailed analysis about the relationship between each specific SNP and the susceptibility to CRC is presented in Figures 2–8.

TABLE 1.

Meta-Analysis of 7 Polymorphisms in CASC8 Gene and SMAD7 Gene and Colorectal Cancer Susceptibility

graphic file with name medi-94-e1884-g002.jpg

Open in a new tab

FIGURE 2.

FIGURE 2

Open in a new tab

Forest plot for gene polymorphism of rs7837328 by ethnicity.

FIGURE 8.

FIGURE 8

Open in a new tab

Forest plot for gene polymorphism of rs12953717 by ethnicity.

Association Between CASC8 Gene Polymorphisms and CRC Risk

Four SNPs on CASC8 gene were analyzed in the current meta-analysis. Studies on rs7837328 showed a low heterogeneity (Tau2 = 0.002, I2 = 0.08%, P = 0.279) and therefore a fixed-effects model was conducted. On the other hand, studies on the other three SNPs (rs7014346, rs6983267, rs10505477) indicated significant heterogeneity (Tau2 = 0.013, I2 = 82.3%, P < 0.001; Tau2 = 0.016, I2 = 86.3%, P < 0.001; Tau2 = 0.004, I2 = 59.8%, P = 0.007, respectively) and hence a random-effects model was used in the meta-analysis.

As shown in Figure 2, the A allele of rs7837328 was significantly associated with an increased risk of CRC as compared to the G allele (OR = 1.17, 95% CI = 1.11–1.23, P < 0.001). In addition, subgroup analyses by ethnicity revealed that the A allele of rs7837328 was evidently related with an increased risk of CRC in Caucasian and Asian (OR = 1.34, 95% CI = 1.12–1.61; OR = 1.17, 95% CI = 1.10–1.24). However, this association was not significant in the African group (OR = 1.09, 95% CI = 0.95–1.25). Similarly, the A allele of rs7014346 was significantly associated with an increased risk of CRC (OR = 1.12, 95% CI = 1.09–1.15, P < 0.001). However, this correlation was only significant in the Caucasian group and there is no such correlation in the Asian and African groups (OR = 1.20, 95% CI = 1.16–1.24; OR = 1.01, 95% CI = 0.86–1.19; OR = 1.13, 95% CI = 0.99–1.30) (Figure 3). Furthermore, the results suggested that the G allele of rs6983267 was significantly associated with an increased risk of CRC (OR = 1.15, 95% CI = 1.13–1.17, P < 0.001) and a similar correlation was presented in the A allele of rs10505477 (OR = 1.12, 95% CI = 1.07–1.17, P < 0.001). For rs6983267, subgroup analyses indicated that there the G allele was significantly associated with the susceptibility to CRC among Caucasian and Asian (OR = 1.11, 95% CI = 1.04–1.18; OR = 1.16, 95% CI = 1.09–1.25), while such correlation was not significant in the African group (OR = 1.22, 95% CI = 0.99–1.52) (Figure 4). For rs10505477, subgroup analyses of Caucasian and Asian were carried out due to the lack of African studies and it revealed that the A of rs10505477 was significantly related with an increased susceptibility to CRC in the Caucasian group (OR = 1.16, 95% CI = 1.12–1.20), while no such significant association was observed in the Asian group (OR = 1.05, 95% CI = 0.95–1.16) (Figure 5).

FIGURE 3.

FIGURE 3

Open in a new tab

Forest plot for gene polymorphism of rs7014346 by ethnicity.

FIGURE 4.

FIGURE 4

Open in a new tab

Forest plot for gene polymorphism of rs6983267 by ethnicity.

FIGURE 5.

FIGURE 5

Open in a new tab

Forest plot for gene polymorphism of rs10505477 by ethnicity.

Association Between SMAD7 Genetic Polymorphisms and CRC Risk

For SMAD7 gene, 3 polymorphisms (rs4939827, rs4464148, rs12953717) were analyzed in this study and significant associations between these SNPs and the susceptibility to CRC were indicated by our analysis. A random-effect model was applied to the SNP of rs4939827 as significant heterogeneity was presented in individual studies (Tau2 = 0.008, I2 = 79.2%, P < 0.001). Conversely, fixed-effects models were applied to SNPs of rs4464148 and rs12953717 as no significant heterogeneity was presented in these 2 SNPs in individual studies (Tau2 = 0, I2 = 0.0%, P = 0.880; Tau2 = 0, I2 = 0.0%, P = 0.464).

As revealed in Table 1, the T allele of rs4939827 was significantly related with an increase risk of CRC (OR = 1.10, 95% CI = 1.05–1.15, P < 0.001). Subgroup analysis based on ethnicity indicated a similar correlation between SNP in rs4939827 and the susceptibility to CRC in the Caucasian group whereas such a correlation was not presented in the Asian and African group (Figure 6). Furthermore, the T allele of rs4464148 and the T allele of rs12953717 were significantly associated with an elevated risk of CRC (OR = 1.13, 95% CI = 1.08–1.17, P < 0.001; OR = 1.16, 95% CI = 1.13–1.20, P < 0.001). However, the subgroup analysis of rs4464148 was not applicable as no studies were found in the Asian and African populations (Figure 7) Furthermore, the T allele of rs12953717 was significantly associated with an increased the risk of CRC among Caucasian and Asian (OR = 1.16, 95% CI = 1.12–1.20; OR = 1.25, 95% CI = 1.09–1.44), while such an association was not presented in the African group (OR = 1.10, 95% CI = 0.95–1.28) (Figure 8).

FIGURE 6.

FIGURE 6

Open in a new tab

Forest plot for gene polymorphism of rs4939827 by ethnicity.

FIGURE 7.

FIGURE 7

Open in a new tab

Forest plot for gene polymorphism of rs4464148 by ethnicity.

Publication Bias

As suggested in Table 1 and Supplement Figure S2a–g, no significant asymmetry could be observed in the funnel plots and results from Begg funnel plot suggested that there was no significant publication bias presented in the study (P = 0.433 for rs7837328, P = 0.776 for rs7014346, P = 0.518 for rs6983267, P = 0.083 for rs10505477, P = 0.087 for rs4939827, P = 0.071 for rs4464148, and P = 0.540 for rs12953717).

DISCUSSION

Recently, a lot of attention has been paid to gene polymorphisms involved in tumorigenesis due to the fast growing interests in cancer research. GWASs have contributed substantially to the identification of common genetic variants related to human cancer. Several studies evidenced that genetics play a critical role in CRC development and progression,24–26 and GWASs have suggested that various genes were associated with the susceptibility to CRC.27 Moreover, recent evidence suggested that CASC8 and SMAD7 gene polymorphisms both play important roles in different cancers including prostate cancer28,29 and breast cancer.19,30 Furthermore, there seems to exist strong associations between gene polymorphisms in CASC8 (rs7837328, rs7014346, rs6983267, rs10505477), SMAD7 (rs4939827, rs4464148, rs12953717), and an increased risk of CRC.8,17,31–37 However, the correlation between these gene polymorphisms and the susceptibility to CRC is still unclear due to various conclusions drawn by individual studies.

For the purpose of providing a comprehensive and consistent conclusion, a meta-analysis of 90 independent case–control studies was carried out and how SNP rs10505477, rs7837328, rs7014346, and rs6983267 located on CASC8 in the 8q24 region and SNP rs4939827, rs4464148, rs12953717 in the SMAD7 region affect CRC tumorigenesis was investigated. Researchers have shown that CASC8 and SMAD7 genes are highly correlated with CRC development and progression.38–40 Subgroup analyses by ethnicity indicated that SNPs of rs7014346, rs10505477, and rs4939827 were significantly associated with an increased risk of CRC in the Caucasian group, whereas SNPs of rs7837328, rs6983267, and rs12953717 were considered as significant risk factors for CRC in both of the Caucasian and Asian group. Besides that, rs4464148 is a risk factor for CRC development and progression in the Caucasian group and the association between rs4464148 SNP and the susceptibility to CRC was unknown in the Asian and African groups due to the lack of relevant studies.

Despite the fact that well-established biological pathways contribute to the majority of CRC risk variants, the functions of some reported loci are still abstruse. The association between multiple SNPs in the chromosome region 8q24 and the increased risk of several solid tumor malignancies, including CRC, has been reported by various independent studies.10,31,41,42 Recent GWASs have suggested that SNP of rs7837328 is significantly correlated with the risk of CRC.43–45 As a result of this, it has been hypothesized that rs7837328 may function through its long-range linkage with causal variants contained in other oncogenes or tumor suppressor genes. Additionally, others have speculated that SNP of rs7837328 may influence the gene expression through long-range cis-regulatory elements.46 The association between rs6983267 and CRC was firstly proposed in 2007 by 3 GWAS,43,45,47 and further investigated by several case–control studies. Tuupanen et al48 reported that rs6983267 might enhance Wnt signaling via affecting binding to T-cell factor-4 (TCF4). Apart from that, the G allele of rs6983267 has been conferred to increase the risk of CRC by interacting with the promoter of MYC oncogenes,48–50 which was an aberrant expression in numerous tumors, including gastric cancer.51 Moreover, a relationship between SNP of rs7014346 and CRC susceptibility was discovered in a GWAS44 and previous study has also suggested that the GA genotype of rs7014346 was significantly associated with a decreased risk of breast cancer. The rs10505477 SNPs, also located in the chr.8q24 region, were significantly associated with the risk of CRC43,45,52 and breast cancer.53,54 Ma et al10 hypothesized that rs10505477 in LncRNA CASC8 was involved in gastric cancer progression and it might serve as a potential prognosis marker in the Chinese population.

GWAS have identified several genomic regions associated with the risk of CRC and these genomic regions include genes in the TGF-β signaling pathway such as SMAD7,44,55BMP2,26,33,56BMP4,26,56 and GREM1.26,57 Phipps et al58 found that rs4939827, located in SMAD7 intron 4, was significantly associated with poorer overall survival status of patients and disease-specific survival status. Rs4939827, encoding an intracellular antagonist of the TGF-β pathway frequently, was revealed to be inactivated in CRC44,55,59–61 and it explains approximately 1% of the familial relative risk of CRC in East Asian.22 Another study revealed the association between SNP of rs4939827 and the risk of CRC in the Croatian population.36 Rs4464148, located in intron 3 of SMAD7 gene, has also been discovered to be correlated with the risk of CRC in European-ancestry populations.55 Besides that, Rs4464148 variant genotype of SMAD7 has been proved to be associated with an increased cancer incidence.62 Meanwhile, rs4464148 has been used for delimiting new groups with high-risk CRC in clinical practice, especially in Poland, Estonia, and Lithuania.63 Dai et al64 discovered that the homozygous variant genotype of rs4464148 was significantly associated with better survival status in CRC stage III patients, as compared with patients having the homozygous wild-type and heterozygous genotypes. Additionally, the rs12953717 of SMAD7, which was reported in 2 GWAS studies,44,55 may be valuable markers for predicting the risk of tumor formation. Empirical evidence suggested that rs12953717 was a common risk marker of lung, colorectal, and gastric cancer in the Chinese Han population.65 Li et al65 discovered that rs12953717 confers a strong association with the above 3 cancer in the Chinese Han population. More importantly, rs12953717 has been discovered to be significantly associated with an increased risk of CRC.17,66

Subgroup analyses revealed that rs7837328, rs12953717, and rs6983267 polymorphisms were significantly associated with an increased risk of CRC in both Asian and Caucasian, while rs7014346, rs4939827, and rs10505477 polymorphisms were significantly associated with an increased risk of CRC in Caucasian. Due to the lack of studies among Asian and African, subgroup analyses were not implemented for rs4464148 which was found to be significantly associated with an increased risk of CRC in Caucasian. The difference in the association among different ethnicities may result from other factors such as socioeconomic environment and race.

Although some inconsistent conclusions on the association between SNPs and the susceptibility to CRC have been clarified in the meta-analysis, some limitations of the meta-analysis should be taken into account. First of all, the limited amount of data did not enable us to determine how the interaction between various gene polymorphisms affects the susceptibility to CRC. Similarly, potential interactions between genetic and nongenetic factors could not be evaluated due to the lack of data. As a result of this, results from the meta-analysis might be affected by various confounding factors and effect modification might be presented in the statistical analysis. To the best of our knowledge, this is the most comprehensive meta-analysis which individually examined the correlation between seven gene polymorphisms and the susceptibility to CRC. Overall, the meta-analysis revealed that all of the 7 SNPs (rs7837328, rs7014346, rs6983267, rs10505477, rs4939827, rs4464148, rs12953717) were significantly associated with the risk of CRC. As a result of this, all of the 7 gene polymorphisms could be considered as potential risk markers for detecting and diagnosing CRC and it may play an important role in the early prophylaxis and control measures to reduce the incidence of CRC. However, race and ethnicity might have significant impact on the detection and diagnose using gene polymorphisms as subgroup analysis indicated that the association between the 7 SNP and the risk of CRC varied significantly in different ethnicities. It is significantly recommended that well-design studies which incorporate different ethnicities together with genetic and nongenetic factors should be carried out in order to assess the interaction between different gene polymorphisms which might be considered as the next benchmark for detecting CRC.

Acknowledgment

This study was supported by Science and Technology Research Key Project of Department of Education of Henan Province (No. 14A320064). We appreciate our colleagues for their constructive comments on this paper.

Footnotes

Abbreviations: CASC8 = cancer susceptibility candidate 8, CRC = colorectal cancer, GWAS = genome-wide association study, LncRNA = long noncoding RNA, NOS = Newcastle-Ottawa Scale, SNP = single nucleotide polymorphism.

Supplemental Digital Content is available for this article.

Kunhou Yao and Long Hua contributed equally to this work.

The authors have no conflicts of interest to disclose.

REFERENCES

  • 1.Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9–29. [DOI] [PubMed] [Google Scholar]
  • 2.Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64:104–117. [DOI] [PubMed] [Google Scholar]
  • 3.Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69–90. [DOI] [PubMed] [Google Scholar]
  • 4.Papagiorgis P. Colorectal cancer: dichotomous or continuum model? Perhaps, a combination of both. Gut 2013; 62:1519–1520. [DOI] [PubMed] [Google Scholar]
  • 5.Ying H, Wang J, Gao X. CCL5-403, CCR5-59029, and Delta32 polymorphisms and cancer risk: a meta-analysis based on 20,625 subjects. Tumour Biol 2014; 35:5895–5904. [DOI] [PubMed] [Google Scholar]
  • 6.Gao X, Duan H, Zhu Z. Association between PTEN IVS4 polymorphism and cancer risk: a meta-analysis. Cancer Biomark 2013; 13:465–470. [DOI] [PubMed] [Google Scholar]
  • 7.Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78–85. [DOI] [PubMed] [Google Scholar]
  • 8.Whiffin N, Hosking FJ, Farrington SM, et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Hum Mol Genet 2014; 23:4729–4737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Peng Q, Lao X, Tang W, et al. XPC Lys939Gln polymorphism contributes to colorectal cancer susceptibility: evidence from a metaanalysis. Diagn Pathol 2014; 9:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Ma G, Gu D, Lv C, et al. Genetic variant in 8q24 is associated with prognosis for gastric cancer in a Chinese population. J Gastroenterol Hepatol 2015; 30:689–695. [DOI] [PubMed] [Google Scholar]
  • 11.Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458:223–227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Li L, Sun R, Liang Y, et al. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J Exp Clin Cancer Res 2013; 32:104–110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chung S, Nakagawa H, Uemura M, et al. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility. Cancer Sci 2011; 102:245–252. [DOI] [PubMed] [Google Scholar]
  • 14.Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464:1071–1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39:645–649. [DOI] [PubMed] [Google Scholar]
  • 16.Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342:1350–1358. [DOI] [PubMed] [Google Scholar]
  • 17.Hu Y, Sun Z, Zhang A, et al. SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer. Tumour Biol 2014; 35:695–699. [DOI] [PubMed] [Google Scholar]
  • 18.Lamora A, Talbot J, Bougras G, et al. Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. Clin Cancer Res 2014; 20:5097–5112. [DOI] [PubMed] [Google Scholar]
  • 19.Kim S, Han J, Lee SK, et al. Smad 7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells. Cancer Lett 2012; 314:147–154. [DOI] [PubMed] [Google Scholar]
  • 20.Zhang Y, Yu Z, Xiao Q, et al. Expression of BAMBI and its combination with Smad7 correlates with tumor invasion and poor prognosis in gastric cancer. Tumour Biol 2014; 35:7047–7056. [DOI] [PubMed] [Google Scholar]
  • 21.Jungert K, Buck A, Buchholz M, et al. Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis 2006; 27:2392–2401. [DOI] [PubMed] [Google Scholar]
  • 22.Zhang B, Jia WH, Matsuo K, et al. Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians. Int J Cancer 2014; 135:948–955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339:b2700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343:78–85. [DOI] [PubMed] [Google Scholar]
  • 25.Aaltonen L, Johns L, Jarvinen H, et al. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res 2007; 13:356–361. [DOI] [PubMed] [Google Scholar]
  • 26.Tomlinson IP, Carvajal-Carmona LG, Dobbins SE, et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet 2011; 7:e1002105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273:1516–1517. [DOI] [PubMed] [Google Scholar]
  • 28.San Francisco IF, Rojas PA, Torres-Estay V, et al. Association of RNASEL and 8q24 variants with the presence and aggressiveness of hereditary and sporadic prostate cancer in a Hispanic population. J Cell Mol Med 2014; 18:125–133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Reinhardt D, Helfand BT, Cooper PR, et al. Prostate cancer risk alleles are associated with prostate cancer volume and prostate size. J Urol 2014; 191:1733–1736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Salot S, Gude R. MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines. Eur J Cancer 2013; 49:492–499. [DOI] [PubMed] [Google Scholar]
  • 31.Yang B, Thyagarajan B, Gross MD, et al. Genetic variants at chromosome 8q24, colorectal epithelial cell proliferation, and risk for incident, sporadic colorectal adenomas. Mol Carcinog 2014; 53 Suppl. 1:E187–E192. [DOI] [PubMed] [Google Scholar]
  • 32.Wei W, Jiang M, Luo L, et al. Colorectal cancer susceptibility variants alter risk of breast cancer in a Chinese Han population. Genet Mol Res 2013; 12:6268–6274. [DOI] [PubMed] [Google Scholar]
  • 33.Peters U, Hutter CM, Hsu L, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet 2012; 131:217–234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wang YP, Zhang J, Zhu HY, et al. Common variation rs6983267 at 8q24.1 and risk of colorectal adenoma and cancer: evidence based on 31 studies. Tumour Biol 2014; 35:4067–4075. [DOI] [PubMed] [Google Scholar]
  • 35.Shen L, Du M, Wang C, et al. Clinical significance of POU5F1P1 rs10505477 polymorphism in Chinese gastric cancer patients receving cisplatin-based chemotherapy after surgical resection. Int J Mol Sci 2014; 15:12764–12777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kirac I, Matosevic P, Augustin G, et al. SMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population. PLoS ONE 2013; 8:e74042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Damavand B, Derakhshani S, Saeedi N, et al. Intronic polymorphisms of the SMAD7 gene in association with colorectal cancer. Asian Pac J Cancer Prev 2015; 16:41–44. [DOI] [PubMed] [Google Scholar]
  • 38.Li M, Gu Y. Quantitative assessment of the influence of common variation rs16892766 at 8q23.3 with colorectal adenoma and cancer susceptibility. Mol Genet Genomics 2015; 290:461–469. [DOI] [PubMed] [Google Scholar]
  • 39.Wang N, Wang L, Yang H, et al. Multiple genetic variants are associated with colorectal cancer risk in the Han Chinese population. Eur J Cancer Prev 2015; 24:1–5. [DOI] [PubMed] [Google Scholar]
  • 40.Rizzo A, De Mare V, Rocchi C, et al. Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells. Carcinogenesis 2014; 35:1536–1546. [DOI] [PubMed] [Google Scholar]
  • 41.Zhang X, Chen Q, He C, et al. Polymorphisms on 8q24 are associated with lung cancer risk and survival in Han Chinese. PLoS ONE 2012; 7:e41930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Grisanzio C, Freedman ML. Chromosome 8q24-associated cancers and MYC. Genes Cancer 2010; 1:555–559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Tomlinson I, Webb E, Carvajal-Carmona L, et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007; 39:984–988. [DOI] [PubMed] [Google Scholar]
  • 44.Tenesa A, Farrington SM, Prendergast JG, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008; 40:631–637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zanke BW, Greenwood CM, Rangrej J, et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007; 39:989–994. [DOI] [PubMed] [Google Scholar]
  • 46.Zhang K, Civan J, Mukherjee S, et al. Genetic variations in colorectal cancer risk and clinical outcome. World J Gastroenterol 2014; 20:4167–4177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Haiman CA, Le Marchand L, Yamamato J, et al. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 2007; 39:954–956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Tuupanen S, Turunen M, Lehtonen R, et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009; 41:885–890. [DOI] [PubMed] [Google Scholar]
  • 49.Pomerantz MM, Ahmadiyeh N, Jia L, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009; 41:882–884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Harismendy O, Frazer KA. Elucidating the role of 8q24 in colorectal cancer. Nat Genet 2009; 41:868–869. [DOI] [PubMed] [Google Scholar]
  • 51.de Souza CR, Leal MF, Calcagno DQ, et al. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS ONE 2013; 8:e64420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.He J, Wilkens LR, Stram DO, et al. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev 2011; 20:70–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Turnbull C, Ahmed S, Morrison J, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010; 42:504–507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Kim HC, Lee JY, Sung H, et al. A genome-wide association study identifies a breast cancer risk variant in ERBB4 at 2q34: results from the Seoul Breast Cancer Study. Breast Cancer Res 2012; 14:R56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Broderick P, Carvajal-Carmona L, Pittman AM, et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 2007; 39:1315–1317. [DOI] [PubMed] [Google Scholar]
  • 56.Houlston RS, Webb E, Broderick P, et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008; 40:1426–1435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Peters U, Jiao S, Schumacher FR, et al. Identification of genetic susceptibility loci for colorectal tumors in a genome-wide meta-analysis. Gastroenterology 2013; 144:799.e24–807.e24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Phipps AI, Newcomb PA, Garcia-Albeniz X, et al. Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer. Gastroenterology 2012; 143:51.e4–54.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Tomlinson IP, Webb E, Carvajal-Carmona L, et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008; 40:623–630. [DOI] [PubMed] [Google Scholar]
  • 60.Song Q, Zhu B, Hu W, et al. A common SMAD7 variant is associated with risk of colorectal cancer: evidence from a case-control study and a meta-analysis. PLoS ONE 2012; 7:e33318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Curtin K, Lin WY, George R, et al. Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev 2009; 18:616–621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Loh YH, Mitrou PN, Wood A, et al. SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study. Cancer Epidemiol 2011; 35:369–374. [DOI] [PubMed] [Google Scholar]
  • 63.Serrano-Fernandez P, Dymerska D, Kurzawski G, et al. Cumulative small effect genetic markers and the risk of colorectal cancer in Poland, Estonia, Lithuania, and Latvia. Gastroenterol Res Pract 2015; 2015:204089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Dai J, Gu J, Huang M, et al. GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes. Carcinogenesis 2012; 33:1327–1331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Li X, Yang XX, Hu NY, et al. A risk-associated single nucleotide polymorphism of SMAD7 is common to colorectal, gastric, and lung cancers in a Han Chinese population. Mol Biol Rep 2011; 38:5093–5097. [DOI] [PubMed] [Google Scholar]
  • 66.Zhang H, Ma H, Xu Y, et al. Association of SMAD7 rs12953717 polymorphism with cancer: a meta-analysis. PLoS ONE 2013; 8:e58170. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES